P029 Circulating MDSCs Derived From Small Cell Lung Cancer Patients Secrete TGF - Beta 1 and Play Roles in Angiogenesis

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.10.053
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Exosomal Leucine-Rich-Alpha2-Glycoprotein 1 Derived From Non-Small-Cell Lung Cancer Cells Promotes Angiogenesis via Transforming-Growth-Factor-Beta Signal Pathway

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2019English

P53 and Angiogenesis in Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
1998English

Neural-Cadherin Expression Associated With Angiogenesis in Non-Small-Cell Lung Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2003English

Circulating Microparticles Are Prognostic Biomarkers in Advanced Non-Small Cell Lung Cancer Patients

Oncotarget
Oncology
2017English

Circulating Tumor Microemboli Diagnostics for Patients With Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

TGF-Beta Suppresses VEGFA-Mediated Angiogenesis in Colon Cancer Metastasis

PLoS ONE
Multidisciplinary
2013English

Platelet-Derived Endothelial Cell Growth Factor Expression Correlates With Tumour Angiogenesis and Prognosis in Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
1997English

Circulating CD14+CD204+ Cells Predict Postoperative Recurrence in Non–Small-Cell Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

Circulating Tumor Cells as a Prognostic Factor in Patients With Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy